BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

ZebiAI

ZebiAI logo

Founded
2019
Geography
United States of America based
Funding
$10 M

ZebiAI Therapeutics is focused on applying machine learning (ML) at all stages of small molecule drug discovery to accelerate target validation and advance new therapeutics for unmet medical needs.


Machine Learning

Technologies

AI Companies (Drug Discovery)   DNA-Encoded Library Companies  

R&D Platform

Thousands of proteins remain understudied with limited or complete lack of understanding about their function and/or relevance to disease pathophysiology. As a result, there is an untapped potential for major scientific advances within the unexplored proteome.

Our Chemome initiative delivers chemical probe molecules for academic researchers to explore the function of their protein of choice. ZebiAI is committed to actively supporting publication of the research results in peer reviewed journals. We are passionate about deepening biological knowledge and accelerating target validation by providing probe compounds for thousands of targets prioritized by the academic community.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet